Corvidia Therapeutics, Inc.
Overview
Corvidia Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of cardiovascular and chronic kidney diseases. As a subsidiary of Novo Nordisk, it leverages cutting-edge technology to target inflammation and oxidative stress pathways.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Corvidia Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Corvidia Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.